Skip to main content
Tech.euFundingExplorerBeta

Roche Venture Fund

Investor profile

Venture capital

Roche Venture Fund has backed 9 European tech companies across 11 funding rounds between 2013 and 2026, joining rounds totalling €462M. Most active in Healthtech. Data as of 4 Nov 2026.

Also recorded as: Roche Ventures

Deals
11
distinct rounds
Companies
9
backed
Active span
2013–2026
14 yrs
Total round €
€462M
sum of rounds joined

Deals by year

distinct rounds / year
Roche Venture Fund — deals by year — interactive chart.
Data table
Roche Venture Fund — deals by year
20132
20151
20171
20211
20221
20231
20253
20261

Top sectors

by deals
Roche Venture Fund — top sectors — interactive chart.
Data table
Roche Venture Fund — top sectors
Healthtech11

Stages

by deals
Roche Venture Fund — stages — interactive chart.
Data table
Roche Venture Fund — stages
Series A4
Series B4
Other2
Series C1

Countries

by deals
Roche Venture Fund — countries — interactive chart.
Data table
Roche Venture Fund — countries
UK4
France2
Switzerland2
Austria1
Denmark1
Spain1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Roche Venture Fund — 11 dealsRoche Venture FundSofinnova Partners — 5 shared deals · click to openSofinnova Partners5AM Ventures — 2 shared deals · click to open5AM VenturesNovartis Venture Fund — 2 shared deals · click to openNovartis Venture FundNovo Holdings — 2 shared deals · click to openNovo HoldingsYsios Capital — 2 shared deals · click to openYsios CapitalAdBio partners — 1 shared deals · click to openAdBio partnersAgent Capital — 1 shared deals · click to openAgent CapitalAsabys Partners — 1 shared deals · click to openAsabys PartnersBioGeneration Ventures — 1 shared deals · click to openBioGeneration VenturesBoehringer Ingelheim Venture Fund — 1 shared deals · click to openBoehringer Ingelheim Venture FundBristol Myers Squibb — 1 shared deals · click to openBristol Myers SquibbCatalio — 1 shared deals · click to openCatalioColumbus Venture Partners — 1 shared deals · click to openColumbus Venture PartnersDraper Esprit — 1 shared deals · click to openDraper EspritEli lilly and company — 1 shared deals · click to openEli lilly and companyEpidarex Capital — 1 shared deals · click to openEpidarex CapitalEQT Life Sciences — 1 shared deals · click to openEQT Life SciencesGilde Healthcare — 1 shared deals · click to openGilde Healthcare

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
GlycoEraSwitzerland2€157M
SpliceBioSpain1€118M
MironidUK1€40M
Vivet TherapeuticsFrance1€38M
NMD PharmaDenmark1€35M
MISSION TherapeuticsUK2€35M
DiogenXFrance1€28M
Horizon DiscoveryUK1€8.1M
MySugrAustria1€4.3M

Biggest deals

top 10 by amount
CompanyStageAmountDate
SpliceBioSeries B€118M2025-06
GlycoEraSeries B€114M2025-05
GlycoEraSeries A€43M2021-11
Vivet TherapeuticsSeries A€38M2017-05
NMD PharmaOther€35M2022-02
DiogenXSeries A€28M2023-05
MISSION TherapeuticsSeries B€24M2013-11
MISSION TherapeuticsOther€11M2025-10
Horizon DiscoverySeries C€8.1M2013-06
MySugrSeries A€4.3M2015-03
← Back to investors